← Eichor
Study identifier: NCT06576466 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Effect of Supplementation With Creatine on the Recovery of Ischemic Stroke

Condition: Stroke, Ischemic  ·  Sponsor: Fundació d'investigació Sanitària de les Illes Balears

PhaseNA
Planned participants92
Who can joinAll sexes, 18 Years to 80 Years
Healthy volunteersNo

About this study

Stroke is a leading cause of disability and the second leading cause of death worldwide. Most strokes are ischemic, caused by acute arterial occlusion. Post-stroke treatment focuses on secondary prevention and rehabilitation, but few treatments address functional recovery. Creatine, a supplement known for improving physical performance, may aid in the recovery of stroke patients, reducing sarcopenia and improving strength among other effects. This pilot study will investigate the effectiveness of creatine supplementation in enhancing physical and functional recovery in ischemic stroke patients. The study will involve a randomized, double-blind clinical trial comparing creatine monohydrate to a placebo.

This description comes directly from the study's public registry record.

Talk to the study team

Raquel Delgado Mederos, PhD  ·  0034971205234  ·  raquel.delgado@ssib.es

Eduard Bargay Pizarro, MD  ·  34 971 20 52 34  ·  eduard.bargay@ssib.es

Always discuss trial participation with your own doctor first.

Locations (1)

IdISBaPalma de Mallorca, Balearic Islands, SpainRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06576466